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Introduction
Multiple sclerosis (MS) is a chronic disabling 
neurological illness with no known cure that 
typically necessitates disease-modifying thera-
pies (DMTs) often having adverse side effects 
(Murray, 2006). DMTs, frequently administered 
via injection, are not curative and patient 
response is varied, impacting motivation for 
adherence in some cases (Holland et al., 2001). 
Moreover, managing MS also involves emo-
tional, relational, occupational, and lifestyle 
adaptations secondary to disease progression 
(Lester et al., 2007) that can further complicate 
treatment. The self-management model devel-
oped from Bandura (2005) addresses people’s 
self-efficacy beliefs, their self-management 
capabilities, and how prepared and motivated 
they are to make changes. Utilizing this model, 
the following study aims to understand the 
extent to which self-efficacy and barriers to 
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self-management capabilities, such as depres-
sion and quality of life (QoL), are related to indi-
viduals’ perceived abilities to manage their care.
Patient activation
Patient engagement in health care, also termed 
patient activation, has been increasingly identified 
as a key component for managing chronic dis-
eases like MS (Forbat et al., 2009; Holman and 
Lorig, 2000), demonstrating positive effects on 
both health outcomes and cost containment 
(Bodenheimer et al., 2002). Patient activation 
embodies a developmental process of patients’ 
willingness and ability to manage health and 
health care; four progressive levels of competency 
have been described, ranging from patients being 
relatively passive and not seeing themselves as 
playing an active role in their health to patients 
having the knowledge and confidence to self-
manage health behaviors and garner additional 
supports when needed (Hibbard et al., 2004).
Higher levels of patient activation have been 
associated with better adherence to treatment, 
improved medical outcomes, and greater satis-
faction with care (Hibbard et al., 2004, 2007; 
Mosen et al., 2007). For example, patients with 
diabetes who had higher levels of activation have 
been found to utilize effective self-management 
behaviors, report less difficulty managing dia-
betes care, (Rask et al., 2009), and have 
improved glycemic (Williams et al., 2005) and 
hypertension control (Naik et al., 2008).
Given the chronic and unpredictable nature 
of MS and the need to engage in lifelong, mul-
tifaceted treatment regimens, it is critical that 
patients be highly engaged in their MS care. 
Although a survey instrument assessing patient 
activation has been validated within the MS 
population (Stepleman et al., 2010), specific 
factors that may facilitate or hamper optimal 
patient activation still need to be identified.
Patient factors
Several salient patient attributes have been asso-
ciated with activation in other patient popula-
tions that may be relevant to MS, including 
demographic characteristics and psychosocial 
variables. Pinpointing these factors would assist 
in (1) provider identification of patients most at 
risk of low activation and related suboptimal 
MS health outcomes and (2) development of 
treatment plans that include additional supports 
to increase engagement in care. Additionally, to 
the extent that some patient attributes impacting 
activation may be malleable (e.g. depression), it 
affords the opportunity for therapeutic interven-
tion that consequently may also impact activa-
tion levels.
Demographic characteristics. Initial work on the 
assessment of patient activation identified that 
higher activation was associated with being 
female, younger, and having more education 
(Hibbard et al., 2004, 2005). However, the 
research subsequently has been less consistent 
regarding the relationship between background 
variables and activation (Skolasky et al., 2008). 
For example, significant differences in patient 
activation with regard to race have also been 
reported, with African Americans reporting 
lower activation in some instances than their 
White counterparts (Alegria et al., 2008; Wil-
liams and Heller, 2007). Conversely, others 
have offered that these findings may be better 
explained by socioeconomic status (SES) 
(Blustein et al., 2008; Rask et al., 2009) and 
health literacy factors (Alegria et al., 2008).
Psychosocial factors. Psychosocial factors need 
also be considered in relation to self-management 
behavior. Variables such as mood and distress 
(Fisher, 2006), self-efficacy (Glasgow et al., 
2001), and QoL (Lahdensuo et al., 1996) 
among others have been found to contribute to 
patients’ ability to initiate and maintain health 
behaviors.
Self-efficacy. Self-efficacy, the belief that 
one can overcome particular challenges and 
carry out a course of action, has been linked 
with chronic illness management (Farrell et al., 
2004). Having high levels of perceived self-
efficacy appears to be more consistently cor-
related with self-management behaviors than 
demographics or other health characteristics 
(Curtin et al., 2008; Joekes et al., 2007). MS-
specific self-efficacy has been found to predict 
adjustment to having MS and self-worth after 
diagnosis (Barnwell and Kavanagh, 1997), and 
has been linked to anticipation of DMT injec-
tion difficulties (Mohr et al., 2001). Because 
self-efficacy levels in patients with MS appear 
to be inversely correlated with severity of 
depression and/or anxiety symptoms (Thornton 
et al., 2006), individuals suffering from these 
conditions may be especially at risk of low lev-
els of activation.
Depression. The role of depression in man-
aging chronic illness has been extensively 
studied. Not only does depression impact QoL 
(Orenius et al., 2013) but depressed patients 
were three times more likely than nondepressed 
patients to be noncompliant with treatment 
recommendations (DiMatteo et al., 2000). The 
extant literature suggests a prevalence of mood 
disorders as high as 50–75 percent for indi-
viduals living with MS (Minden et al., 2006). 
Greater levels of depression have been related 
to lower levels of illness management self- 
efficacy (Lester et al., 2007) and use of avoid-
ance coping (Mohr et al., 1997), while treat-
ment of depression has been found to increase 
adherence to DMTs (Mohr et al., 1997). Persons 
with depressive symptoms have been found to 
be less likely to increase activation or improve 
their self-management behaviors than those 
without depressive symptoms (Hibbard et al., 
2007). Conversely, higher levels of patient acti-
vation have been associated with lower severity 
of depressive symptoms in patients following 
spine surgery (Skolasky et al., 2008). Given 
the frequency of depression in MS and the pro-
found impact it can have on initiation and main-
tenance of health behaviors (Wallbridge et al., 
2008), further investigation of the relationship 
between activation and depression in MS is 
warranted.
Quality of life. Patients’ perceptions of their 
QoL have also been linked to practice of self-
management strategies. Hibbard et al. (2007) 
found that better health-related QoL was asso-
ciated with greater activation. Furthermore, 
patients scoring at the highest activation level 
were five times more likely to report better 
QoL than patients in the lowest activation level 
(Mosen et al., 2007). Persons with MS tend to 
have a significantly lower QoL than the general 
population (Montel and Bungener, 2007) related 
to a variety of factors including physical fac-
tors, psychological factors such as depression 
and cognitive complaints, and social factors 
such as economic disadvantage (De Judicibus 
and McCabe, 2007; McCabew and De Judici-
bus, 2005). One study identified depression as 
the single most important predictor of QoL in 
persons with MS (Amato et al., 2001). However, 
QoL in MS is not static and is higher in individu-
als who use positive coping skills (Goretti et al., 
2009) and who are more physically active (Motl 
and Snook, 2008). QoL has been an important 
outcome in health research but may also in turn 
be a predictor of patient activation given than 
perceived high QoL may motivate individuals to 
stay activated in order to retain it.
Using a self-management model, the pur-
pose of this study was to examine the contribu-
tions of patient demographic and psychosocial 
variables to activation levels in persons with 
MS. Better clarification of these relationships 
could serve to identify individuals at risk of low 
activation levels as well as possible therapeutic 
targets for activation intervention in MS.
Methods
Participants
Participants were recruited from a MS Center 
in an academic medical institution in the 
Southeastern United States. Of the 199 partici-
pants who consented to participate in the study, 
the majority were female (n = 163, 82%), 
Caucasian (n = 137, 68.8%), married (n = 120, 
60%), had at least some college (n = 144, 71%), 
were unemployed (n = 109, 55%), and have been 
diagnosed with relapse-remitting MS (n = 131, 
66%). The mean age was 46.24 years (standard 
deviation (SD) = 10.83 years) (see Table 1).
Measures
Demographics. Participants were asked to 
answer questions regarding their ethnicity/race, 
gender, age, marital status, income, education, 
date of diagnosis, type of MS, and disability/
employment status.
Beck Depression Inventory–II. The Beck Depres-
sion Inventory–II (BDI-II; Beck et al., 1996) is a 
21-item, multiple-choice self-report instrument 
for assessment of somatic (13 items) and affec-
tive (8 items) depression symptoms. Individual 
item responses range from 0 to 3, with higher 
item scores indicating greater endorsement/fre-
quency of that symptom. Item scores are totaled 
and higher scores indicate higher severity of 
symptoms. The BDI-II items have been utilized 
and validated in MS samples with good reliabil-
ity (Mohr et al., 2001) and Cronbach’s alpha 
was .92 in our sample.
Patient Activation Measure–13. The Patient Acti-
vation Measure–13 (PAM-13; Hibbard et al., 
2005) is the short form of the 22-item PAM 
developed by Hibbard et al. (2004) to assess 
patient knowledge, skill, and confidence in dis-
ease self-management. The PAM-13 contains 
items such as “I know how to prevent further 
problems with my health condition” that par-
ticipants rate from “strongly agree” to “strongly 
disagree.” The PAM-13 yields a total scale 
score from 0 to 100, with higher scores indicat-
ing higher activation. The PAM-13 items have 
been utilized in many patient populations with 
good reliability (Hibbard et al., 2005) including 
in MS (Stepleman et al., 2010). Cronbach’s 
alpha was .88 in this study.
The MS Self-Efficacy Scale. The MS Self-Efficacy 
Scale (MSSE) (Schwartz et al., 1996) is an 
18-item scale designed to assess patient cer-
tainty of being able to achieve a specific func-
tion (9-item subscale) or to control aspects of 
their MS (9-item subscale). An example func-
tion item is “As of now, how certain are you 
that you can walk 100 feet on flat ground?” 
whereas a control subscale item is “As of now, 
how certain are you that you can deal with the 
Table 1. MS clinic sample demographics.
M (SD) n %
Sample 199 100.00
Female 163 81.90
Age 46.24 (10.83)
Years since 
diagnosis
8.30 (6.84)
Race
Native American 1 .50
African American 54 27.10
 Hispanic/Latino 2 1.00
 Caucasian 137 68.80
 Biracial 4 2.00
Marital status
 Single/never 
married
30 15.10
 Married 120 60.30
 Living with 
partner
3 1.50
 Separated 7 3.50
 Divorced 34 17.10
 Widowed 5 2.50
Education
Some high school 9 4.50
 GED/high school 
diploma
45 22.70
Some college 49 24.70
 2-year college/
Associate’s 
degree
32 16.20
 4-year college/
Bachelor’s degree
32 16.10
 Master’s 23 11.60
 Doctoral/PhD 2 1.00
 Professional 
degree
6 3.00
Employment status
 Full-time 59 30.30
 Part-time 14 7.20
 Unemployed 109 55.90
 Retired 10 5.10
 Disability 3 1.50
Type of MS
 Relapse-remitting 131 68.60
 Progressive 8 4.20
 Secondary-
progressive
15 7.90
 Unsure 37 19.40
MS: multiple sclerosis; SD: standard deviation; GED: 
General Equivalency Diploma.
frustration of MS.” Each item is scored from 10 
to 100 in 10-point increments, with higher indi-
cating a greater degree of certainty. Subtotals 
are calculated for the function and control sub-
scales and a total MSSE score is obtained. The 
MSSE items have been shown to have high 
internal consistency and test–retest reliability 
(Schwartz et al., 1996). In this study, Cron-
bach’s alpha was .96, .94, and .96, for the full 
scale, function subscale, and control subscale, 
respectively.
Leeds Multiple Sclerosis Quality of Life. The Leeds 
Multiple Sclerosis Quality of Life (LMSQOL) 
(Ford et al., 2001) is an 8-item self-report meas-
ure that assesses well-being in patients with 
MS. It was designed to measure aspects of well-
being that may be less related to physical health 
status. It includes statements such as “I have felt 
happy about the future” that are rated from 0 
(Not at all) to 3 (Very Much). Total scores range 
from 0 to 24, with higher scores indicating 
higher levels of well-being. The LMSQOL 
items have been shown to have acceptable reli-
ability (α = 0.79) in the literature (Ford et al., 
2001) and was near identical (α = 0.80) to this 
study.
Procedure
The survey data were collected as patients attended 
their routine MS Center visits. Institutional 
Review Board approval was received prior to 
study initiation. Adult patients who were 
assessed by their neurologist as having defini-
tive MS and limited cognitive impairment were 
eligible for participation. Participation was vol-
untary; verbal and written informed consent was 
obtained. Survey completion averaged 25 min-
utes and there was no participation remunera-
tion. When requested, assistance with reading or 
marking items was provided.
Results
Preliminary analyses
Cronbach’s alpha coefficients were calculated 
for all survey instruments with the current 
sample and found to range from .80 to .96, indi-
cating good to excellent reliability.
Analyses of variance (ANOVAs) and t-tests 
were conducted to assess demographic differ-
ences in patient activation. Findings were not 
significant for age, gender, ethnicity, and mari-
tal status and were therefore not included in 
subsequent analyses. The t-test was significant 
for type of MS and patient activation, t(186) = 
2.95, p < .01. Patients with relapse-remitting 
MS (M = 64.31, SD = 11.93) scored signifi-
cantly higher on the PAM than patients with a 
progressive MS (M = 57.39, SD = 10.54).
Level of education was collapsed into (1) 
high school education and below, (2) patients 
with some college or a 2-year degree, and (3) 
patients with a 4-year degree and above. The 
one-way ANOVA evaluating the relationship 
between education level and patient activation 
was significant, F(2, 192) = 15.68, p < .001. 
The Gabriel post hoc testing (selected for group 
size differences) identified that those with an 
education level of high school and below (n = 
52, M = 59.08, SD = 10.25) had significantly 
lower patient activation scores than individuals 
with some college or a 2-year degree (n = 80, 
M = 60.72, SD = 11.85) or than those with a 
4-year degree.
Employment was collapsed into participants 
employed (full or part-time) and participants 
not employed (retirement, unemployment, and 
disabled). The independent t-test was signifi-
cant, t(190) = 2.65, p < .05. Non-employed par-
ticipants (M = 61.48, SD = 12.27) had 
significantly lower activation than those who 
were employed (M = 66.12, SD = 10.90).
Correlational analysis
Correlational analyses of the psychosocial and 
patient activation variables (with Bonferroni 
correction) are presented in Table 2. Depression 
was significantly inversely correlated with 
patient activation (r = −.43, p < .01), self-efficacy 
(r = −.55, p < .01), and QoL (r = −.72, p < .01). 
Self-efficacy and QoL were significantly posi-
tively associated with patient activation (r = 
.50, p < .01; r = .42, p < .01) and with each other 
(r = .62, p < .01).
Hierarchical regression analyses
A hierarchical regression was conducted in 
order to examine the unique and combined con-
tribution of depression, QoL, and MS self-effi-
cacy to patient activation (Figure 1). Variable 
blocks were entered in order from those 
deemed least malleable and most physically 
determined to those most amenable to behav-
ioral intervention and influenced by percep-
tion and attitude. Demographic variables 
associated with patient activation (education 
and employment) were entered first. MS phys-
ical health-related variables (type of MS and 
the function subscale of the MSSE) were 
entered second. BDI-II scores were entered 
third, and the fourth block consisted of the 
LMSQOL and the control subscale of the 
MSSE. The MSSE subscales were entered 
into different blocks because the function sub-
scale involves items about performing physi-
cal tasks (walking 100 feet on flat ground) 
whereas the control subscale involves control-
ling certain aspects of MS (dealing with the 
frustration or uncertainty of MS).
All regression blocks were significant, 
accounting for 35 percent of the total variance 
in patient activation (Table 2). Demographics 
accounted for 10 percent of the variance, with 
education related to patient activation but not 
employment. The second block accounted for 
an additional 11 percent of the variance; MSSE 
function was significant but MS type was not. 
Depression accounted for another 5 percent of 
the variance. The fourth block accounted for an 
additional 8 percent of the variance; MSSE con-
trol was related to patient activation, whereas 
LMSQOL was not.
Discussion
Results of this study provide some insight into 
factors that may contribute to patient activation 
in patients with MS and generally concur with 
past findings about patient activation in relation 
to self-efficacy, depression, and QoL.
In the hierarchical regression, education 
level was associated with patient activation. 
This is consistent with Hibbard et al.’s (2004) 
initial patient activation research and other 
studies (Williams and Heller, 2007). Lower lev-
els of education also have been associated with 
lower health literacy (Williams et al., 1998). 
Since MS treatment regimens can be complex, 
patients with low levels of health literacy may 
have more difficulty understanding and com-
plying with treatment, presenting a real chal-
lenge to MS care.
In terms of physical variables, MS type was 
not related to patient activation in the model 
though the progressive MS sample was quite 
small. Although preliminary, this finding cau-
tiously supports other findings indicating that 
although patient activation may fluctuate over 
Block 4
Block 3
Block 2
Block 1
Quality of Life and M.S. 
Self-Efficacy
M.S. related variables
Demographic Variables
Depression
Least malleable, most 
physically determined
Most malleable, least
physically determined
Figure 1. Hierarchical regression framework.
time, it is not necessarily related to changes in 
health status or serious adverse health events, 
and instead may be associated with other fac-
tors such as age or self-reported health at base-
line (Chubak et al., 2012). In contrast, the 
function subscale of the MSSE, assessing self-
perception of being able to handle many physi-
cally related functions, was related to patient 
activation. Persons with higher certainty that 
they could perform these functional activities of 
daily living had higher levels of patient activa-
tion. This is consistent with the findings by 
Chiu et al. (2011) where persons with MS who 
had better perception of their ability to perform 
physical activity perceived fewer barriers to 
activity, resulting in higher physical activity 
levels. Overall, it seems a plausible hypothesis 
that health status or changes in health status are 
less related to changes in patient activation than 
perception of health and function.
Although the majority of participants (52%) 
scored in the minimal depression range on the 
BDI, many (47.3%) had totals on the BDI-II 
that reflect higher symptomatology. Our 
severity distribution was similar to that of 
other MS samples (Patten et al., 2003; Siegert 
and Abernethy, 2005) and supports the associa-
tion of depression and patient activation found 
in the literature (Hibbard et al., 2007). Although 
the cross-sectional nature of our data hinders 
any directional interpretation of these data, 
identifying individuals with depression may 
also identify those at risk of, or who have, low 
activation; intervention in either could result in 
improvement in both.
The control subscale of the MSSE accounted 
for a significant amount of the variance in 
patient activation over and above depression. 
Low self-efficacy has been associated with low 
levels of patient activation, low hope, and low 
locus of control (Skolasky et al., 2008). The 
PAM measure does itself contain self-efficacy-
type items: “I am confident I can figure out 
solutions when new problems arise with my 
health condition,” so this overlap may account, 
in part, for this finding relationship.
Even though QoL has been related to patient 
activation in prior studies (e.g. Hibbard et al., 
2007), QoL was not significantly related to 
patient activation in our model. Although scores 
on the QoL and the PAM were positively cor-
related in our study, QoL does not appear to 
account for additional variance in this model. 
This could be due to the fact that the Multiple 
Sclerosis Quality of Life (MSQOL) instrument 
used in this study is a very broad and general 
measure of QoL. A more specific measure, such 
as the multidimensional MSQOL-54 (Vickrey 
et al., 1995) should be considered for future 
studies.
Limitations
Limitations include the geographically 
restricted sample from a single site and under-
representation of men, even when accounting 
for lower rates of MS in men. Although we had 
good representation of African Americans and 
Caucasians, other racial/ethnic minority groups 
were not as well represented. The findings also 
may not be reflective of the experience of per-
sons with progressive MS given the small sam-
ple in our study. The cross-sectional design 
Table 2. Hierarchical regression analyses of 
depression, QoL, SE to the PAM.
Variable R2 R2change F df β
Demographic 
variables
.10 .10 7.64* 2
 Employment −.13
 Education .27*
MS variables .21 .11 9.43* 2
Type of MS −.06
MSSE function .34*
Biopsychosocial .27 .05 9.95* 1
 BDI-II −.26*
Psychological 
variables
.35 .08 7.92* 2
 LMSQOL .13
MSSE control .38*
QoL: quality of life; SE: self-efficacy; PAM: Patient Activa-
tion Measure; df: degrees of freedom; MS: multiple sclero-
sis; MSSE: MS Self-Efficacy Scale; BDI-II: Beck Depression 
Inventory–II; LMSQOL: Leeds Multiple Sclerosis Quality 
of Life.
*p > .05.
limits directional interpretation of the relation-
ships between the variables and patient activa-
tion. Other limitations include reliance on 
self-report measures and not controlling for 
treatment differences (whether patients were 
receiving DMTs, antidepressants, etc.).
Implications
Activated patients respond differently than non-
activated patients to information from the medi-
cal provider, suggesting that assessment of 
patient activation can help target how to tailor 
physician messages (Ledford, 2012). Several 
studies have focused on increasing patient acti-
vation by tailoring coaching to patient activation 
level (Hibbard et al., 2009; Shively et al., 2013) 
or by intervening at the communication level, 
helping patients build question formulation 
skills prior to their visit with the physician 
(Deen et al., 2011). These results are very 
encouraging given the impact of patient activa-
tion on self-management behaviors. However, 
few studies have focused on determining what 
psychosocial variables and potential barriers 
are associated with patient activation in persons 
with MS.
Based on the strong education-related find-
ings in this study, it is possible to surmise that 
targeting health literacy could be helpful in 
improving patient activation in MS. Becoming 
activated not only involves increasing skills 
and confidence, but also knowledge. Some 
basic literacy skills are important to attain this 
knowledge. Greene et al. (2005) found that 
those with adequate health literacy levels had 
patient activation levels higher than those 
with inadequate or marginal health literacy 
levels. Although some efforts to overcome 
health literacy barriers have been under-
whelming (e.g. Williams et al., 1998), other 
findings do suggest that increased health lit-
eracy may be helpful in self-management 
behaviors (Kim et al., 2004) and worthy of 
additional study. Administering a brief health 
literacy questionnaire such as the Test of 
Functional Health Literacy in Adults (Baker 
et al., 1999) as part of the initial patient assess-
ment could help identify patients who may 
need more education regarding the MS process 
and treatment. Another target for patient acti-
vation intervention may be MS-self efficacy. 
One example in the literature is Luszczynska 
and Tyrburcy’s (2008) self-efficacy interven-
tion on exercise for cardiovascular and diabe-
tes patients, which demonstrated moderate 
effects.
Finally, according to our findings, depres-
sion was also a key factor in patient activation. 
Depression is common and often goes 
untreated, especially in minorities (Gonzalez 
et al., 2010). Furthermore, the patient activa-
tion literature suggests that depressed individu-
als may be at increased risk of low activation, 
particularly when they belong to low SES. 
Addressing depression may be a key element to 
improving patient activation, especially given 
the availability of high-quality, effective 
depression care.
Conclusion
The results of this study provide additional 
insight into the individual factors that affect 
patient activation in persons living with MS. 
Although several interventions have success-
fully increased patient activation, it is helpful to 
know what other variables associated with 
patient activation could be targeted, especially 
in the MS population where multiple factors 
influence patient outcomes. Further research 
should examine the relationship between patient 
activation in MS and specific health outcomes 
using longitudinal designs to assess change 
over time.
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